PharmaEssentia Accelerates Global Expansion with US and Japan Drug Approvals and US$46 Million Manufacturing Investment ...

The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...

HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and ...

Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...

Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon ...

NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...

Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines.

IVI Institute, the global leader in fertility care, announced that The World Egg and Sperm Bank (TWESB), a trusted provider ...

Pumitamig is the class's clearest test of whether targeting PD-L1 rather than PD-1 matters. BioNTech's timelines are also the ...

Under the terms of the agreement, Rona will receive upfront and near-term milestone payments of up to $100M and is eligible ...

Funding Will Accelerate Development of a Nanofluidic Antiretroviral Implant Designed to Deliver Continuous HIV Protection for ...